Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
The Doctors of USC
A Phase II, Multi-Center, Open-Label, Randomized Study Evaluating the Efficacy and Safety of FOLFIRI + MEHD7945A versus FOLFIRI + Cetuximab in Second-Line Patients with KRAS Wild-Type Metastatic Colorectal Cancer.
Open to Accrual
Chemotherapy: Systemic, Immunotherapy
Defintions of terms and FAQ about clinical trials.
Heinz Josef Lenz, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Taison Tran, D.M., Khatchik Karakozian, D.M., Catherine Ticong, R.N.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.